Creo Medical is progressing its three-part strategy which will see the company continue to commercialise its core portfolio of products, acquire complementary businesses (both distribution and technology) and partner its platforms with third-party medical device developers. To support this strategy the company has announced its has conditionally raised c£31m (gross) via an equity placing with an open offer available to raise up to £5m. We continue to see significant market opportunities for Creo ....

16 Aug 2021
Cenkos: Creo Medical Group Plc -- Build, Buy, Partner

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Creo Medical Group Plc -- Build, Buy, Partner
Creo Medical Group Plc (CREO:LON) | 13.2 0 0.0% | Mkt Cap: 54.7m
- Published:
16 Aug 2021 -
Author:
Chris Donnellan -
Pages:
75 -
Creo Medical is progressing its three-part strategy which will see the company continue to commercialise its core portfolio of products, acquire complementary businesses (both distribution and technology) and partner its platforms with third-party medical device developers. To support this strategy the company has announced its has conditionally raised c£31m (gross) via an equity placing with an open offer available to raise up to £5m. We continue to see significant market opportunities for Creo ....